Details:

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports
• Personal Author:
  Smith, Nicole M. ; Bresee, Joseph S. ; Shay, David K. ; Uyeki, Timothy M. ; Cox, Nancy (Nancy J.) ; ... More +

  Smith, Nicole M. ; Bresee, Joseph S. ; Shay, David K. ; Uyeki, Timothy M. ; Cox, Nancy (Nancy J.) ; Strikas, Raymond A. Less -
• Corporate Authors:
  United States. Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.)

  United States. Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.) Less -
• Description:
  "This report updates the 2005 recommendations by the Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2005;54[No. RR-8]:1--44). The 2006 recommendations include new and updated information. Principal changes include 1) recommending vaccination of children aged 24--59 months and their household contacts and out-of-home caregivers against influenza; 2) highlighting the importance of administering 2 doses of influenza vaccine for children aged 6 months--<9 years who were previously unvaccinated; 3) advising health-care providers, those planning organized campaigns, and state and local public health agencies to a) develop plans for expanding outreach and infrastructure to vaccinate more persons than the previous year and b) develop contingency plans for the timing and prioritization of administering influenza vaccine, if the supply of vaccine is delayed and/or reduced; 4) reminding providers that they should routinely offer influenza vaccine to patients throughout the influenza season; 5) recommending that neither amantadine nor rimantadine be used for the treatment or chemoprophylaxis of influenza A in the United States until evidence of susceptibility to these antiviral medications has been re-established among circulating influenza A viruses; and 6) using the 2006--07 trivalent influenza vaccine virus strains: A/New Caledonia/20/1999 (H1N1)-like, A/Wisconsin/67/2005 (H3N2)-like, and B/Malaysia/2506/2004-like antigens. For the A/Wisconsin/67/2005 (H3N2)-like antigen, manufacturers may use the antigenically equivalent A/Hiroshima/52/2005 virus; for the B/Malaysia/2506/2004-like antigen, manufacturers may use the antigenically equivalent B/Ohio/1/2005 virus." - p. 1
• Subjects:
  [+]

  Antiviral Agents / Therapeutic Use Disease Outbreaks / Prevention & Control Influenza, Human / Drug Therapy Influenza A Virus Influenza B Virus Influenza Vaccines / Administration & Dosage Mass Vaccination Vaccination / Standards
• Source:
  Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 2006; v. 55, no. 10
• Series:
  Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  1057-5987 (print);1545-8601 (digital);
• Pubmed ID:
  16874296
• Document Type:
  Journal Issue
• Genre:
  Practice Guideline
• Pages in Document:
  48 pdf pages
• Volume:
  55
• Issue:
  10
• Collection(s):
  Advisory Committee on Immunization Practices (ACIP) Guidelines and Recommendations Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  [+]

  urn:sha-512:33de8aee05423504f516da142c1889b476ca8869f80f9baa2033d6dbe2d92383f8fd1152987bd832470af1dc15a15970b004211280e20de8b798e5fae848fe06
• Download URL:
  https://stacks.cdc.gov/view/cdc/6735/cdc_6735_DS1.pdf
• File Type:
  [PDF-581.55 KB]